GFC Life Science Co., Ltd. logo

GFC Life Science Co., Ltd. (388610)

Market Closed
11 Aug, 06:30
KRX SM KRX SM
6,300. 00
+220
+3.6184%
41.35B Market Cap
- P/E Ratio
- Div Yield
7,606 Volume
- Eps
6,080
Previous Close
Add Transaction
Day Range
6,080 6,380
Year Range
4,460 22,400
Want to track 388610 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

GFC Life Science Co., Ltd. (388610) Statistics

Valuation metrics

Market Cap 41.35B
Enterprise value 38.05B
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) 2.3
Price/Book (mrq) -
Enterprise Value/Revenue 2.15
Enterprise Value/EBITDA 18.1

Overview

Shares outstanding 5.24M
Float 3.33M
Shares short -
% Held by insiders 0.35%
% Held by institutions 0.1%
Average volume (10 days) 26.62K
Average volume (90 days) 37.82K

Price summary

52-Week low 4,460
52-Week high 22,400
Beta 0.98
50-Day moving average 9,609.6
200-Day moving average 14,239.35

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 3:1
Last split Date 24 Jul 2023

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin 0.03%
Operating margin 0.02%

Operational effectiveness

Return on assets 0.01%
Return on equity 0.03%

Income Statement

Revenue (ttm) 17.71B
Revenue per share (ttm) 3,677.58
Quarterly revenue growth (yoy) 0.04%
Gross profit (ttm) 8.51B
EBITDA 2.19B
Net income to common (ttm) 555.43M
Diluted EPS (ttm) -
Quarterly earnings growth (yoy) -0.87%

Balance Sheet

Total cash (mrq) 7.77B
Total cash per share (mrq) 1,480.88
Total debt (mrq) 7.52B
Total Debt/Equity (mrq) 31.61
Current ratio (mrq) 5.6%
Book value per share (mrq) -

Cash Flow

Cash flow statement 1.37B
Levered free cash flow (LFCF) -6.66B